Protocol · Cardiovascular Health
Microangiopathy (Small Vessel Disease) Supportive Care Protocol
Alpha-Lipoic Acid and Vitamin B1 (Benfotiamine) are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Microangiopathy (Small Vessel Disease) Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Alpha-Lipoic Acid | Amount listed: 600–1,200 mg daily in divided doses | Potent antioxidant that improves endothelial function and reduces oxidative damage to small vessels | Not graded yet | ||
| Vitamin B1 (Benfotiamine) | Amount listed: 150–300 mg benfotiamine daily | High-dose thiamine reduces advanced glycation end products and protects small vessels | Not graded yet | ||
| Supporting stackListed as additions to the core | |||||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | Improve endothelial function; anti-inflammatory effects protect blood vessels | Not graded yet | ||
| Vitamin D | Amount listed: 2,000–4,000 IU daily | Supports vascular health; deficiency linked to endothelial dysfunction | Not graded yet | ||
| Coenzyme Q10 | Amount listed: 100–300 mg daily | Supports mitochondrial function in endothelial cells; reduces oxidative stress | Not graded yet | ||
| Magnesium | Amount listed: 300–400 mg daily | Supports vascular smooth muscle function and reduces vascular stiffness | Not graded yet | ||
| Grape Seed Extract | Amount listed: 150–300 mg daily | Proanthocyanidins support capillary integrity and microvascular function | Not graded yet | ||
| L-Arginine | Amount listed: 3–6 g daily in divided doses | Nitric oxide precursor that improves endothelial function | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Microangiopathy (Small Vessel Disease). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Each opens third-party tested products, matched to the dose above where we can.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
How this protocol works
In plain language
Microangiopathy refers to disease of the small blood vessels (capillaries, arterioles, and venules). It most commonly occurs in diabetes (diabetic microangiopathy) affecting the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy). It can also occur in hypertension, autoimmune conditions, and other diseases. The small vessel damage is caused by chronic high blood sugar, oxidative stress, inflammation, and advanced glycation end products (AGEs) that damage vessel walls and reduce blood flow.
CRITICAL: Microangiopathy treatment requires addressing the underlying cause - most importantly, tight blood sugar control in diabetes and blood pressure management. Screening for diabetic complications (eye exams, kidney function tests, foot exams) is essential. Once damage occurs, it may be irreversible, so prevention is key. Medications (ACE inhibitors, ARBs) protect kidneys; laser treatment can prevent vision loss from retinopathy. These supplements support vascular health but are adjunctive to medical management and don't replace optimal diabetes/blood pressure control.
Alpha-Lipoic Acid* is a powerful antioxidant that has been well-studied for diabetic microangiopathy. It improves endothelial function and has been shown to help with diabetic neuropathy.
Benfotiamine* (fat-soluble vitamin B1) reduces the formation of AGEs, which are a major cause of microvascular damage in diabetes. Clinical trials show it can protect against microangiopathy.
Omega-3 Fatty Acids* reduce inflammation and improve endothelial function in small vessels.
Vitamin D* deficiency is associated with endothelial dysfunction, and supplementation may support vascular health.
Coenzyme Q10* supports mitochondrial function in blood vessel cells and reduces oxidative stress.
Magnesium* supports vascular function and is often low in people with diabetes.
Grape Seed Extract* contains proanthocyanidins that support capillary integrity.
L-Arginine* is a nitric oxide precursor that helps blood vessels dilate properly.
Expected timeline: Preventing progression requires consistent management over years. Supplement benefits are typically assessed over months with monitoring of relevant biomarkers.